Prestige Consumer Healthcare (PBH) Free Cash Flow (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Free Cash Flow of $75.3 million in Q4 2025, up 35.89% quarter-over-quarter from $55.4 million in Q3 2025, and up 18.47% on a YoY basis from $63.5 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Free Cash Flow (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Free Cash Flow history runs 16 years deep, the most recent figure standing at $75.3 million for Q4 2025.
- In Q4 2025, Free Cash Flow rose 18.47% year-over-year to $75.3 million; the TTM figure through Dec 2025 stood at $267.2 million (up 7.44% YoY), while the FY2025 annual figure was $243.3 million, up 1.64% from the prior year.
- Free Cash Flow was $75.3 million for Q4 2025 at Prestige Consumer Healthcare, up from $55.4 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $78.2 million in Q2 2025 to a low of $46.6 million in Q2 2023.
- Historically, Free Cash Flow has averaged $60.9 million across 5 years, with a median of $59.0 million in 2021.
- The sharpest annual moves came in 2021 and 2023: Free Cash Flow soared 47.29% in 2021, then retreated 18.51% in 2023.
- A 5-year view of Free Cash Flow shows it stood at $64.1 million in 2021, then fell by 17.06% to $53.1 million in 2022, then jumped by 30.74% to $69.5 million in 2023, then declined by 8.57% to $63.5 million in 2024, then gained by 18.47% to $75.3 million in 2025.
- The last three Free Cash Flow figures came in at $75.3 million (Q4 2025), $55.4 million (Q3 2025), and $78.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 136.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 123.09 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 46.40 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.27 Bn | 157.37 Mn | 75.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75.26 Mn |
| Dec 31, 2025 | 75.26 Mn |
| Sep 30, 2025 | 55.38 Mn |
| Sep 30, 2025 | 55.38 Mn |
| Jun 30, 2025 | 78.18 Mn |
| Jun 30, 2025 | 78.18 Mn |
| Mar 31, 2025 | 58.37 Mn |
| Mar 31, 2025 | 58.37 Mn |
| Dec 31, 2024 | 63.53 Mn |
| Dec 31, 2024 | 63.53 Mn |
| Sep 30, 2024 | 67.77 Mn |
| Sep 30, 2024 | 67.77 Mn |
| Jun 30, 2024 | 53.62 Mn |
| Jun 30, 2024 | 53.62 Mn |
| Mar 31, 2024 | 63.76 Mn |
| Mar 31, 2024 | 63.76 Mn |
| Dec 31, 2023 | 69.48 Mn |
| Dec 31, 2023 | 69.48 Mn |
| Sep 30, 2023 | 59.53 Mn |
| Sep 30, 2023 | 59.53 Mn |